US healthcare giant Johnson & Johnson has announced new long-term data from the QUASAR late-term study showing that Tremfya ...

Israel-based generics giant Teva Industries and France’s Medincell announced that the US Food and Drug Administration has accepted the New Drug Application for olanzapine extended-release injectable ...

Japan’s Chugai today announced that it launched Elevidys intravenous infusion (delandistrogene moxeparvovec), which received ...

UK pharma major AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax has been approved in the USA as the ...

Atlanta, USA-based clinical-stage pharmaceutical company Altesa BioSciences has announced a $75 million oversubscribed Series ...

US pharma giant Merck & Co and hospital system Mayo Clinic have announced a research and development agreement to apply artificial intelligence (AI), advanced analytics and multimodal clinical data, ...

Danish allergy immunotherapy specialist ALK Abello has announced that Henriette Mersebach will step down imminently as executive vice president, research and development, and as a member of the board.

Swiss pharma giant Novartis today announced that Pluvicto (plutetium-177 vipivotide tetraxetan) has received MHRA approval ...

Lonza (SWX: LONN) has bolstered its advanced synthesis offering to increase phase-appropriate support for the discovery and ...

The Russian government has begun a procedure for the creation of the list of vital and essential drugs for 2026. It is ...

US pharma giant Merck & Co has announced positive second RSV season findings from the Phase III SMART trial of Enflonsia (clesrovimab) in infants and children at increased risk for severe respiratory ...

Roche has announced that the US Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for giredestrant, an investigational oral therapy, in combination with ...